What is the difference between HIV-1 and HIV-2?

What is the difference between HIV-1 and HIV-2?

HIV-1 is the most common type of HIV and accounts for 95% of all infections, whereas HIV-2 is relatively uncommon and less infectious. HIV-2 is mainly concentrated in West Africa and the surrounding countries. HIV-2 is less fatal and progresses more slowly than HIV-1.

What is HIV-1 and HIV-2 test?

The HIV antibody test advised by the CDC is the HIV-1/2 antigen/antibody combination immunoassay test. If you test positive for HIV, the CDC advises the following follow-up tests: HIV-1/HIV-2 antibody differentiation immunoassay. This test is to confirm HIV and find out if you have HIV-1 or HIV-2.

What are HIV epidemiological determinants?

Behavioral risk factors for HIV transmission among heterosexuals include number of sex partners, frequency of unprotected intercourse, commercial sex, a history of or concurrent infection with an STD, lack of male circumcision, and anal intercourse; many women are at risk only because they have unprotected intercourse …

What are the evolutionary origins of HIV-1 and HIV-2?

From Africa, HIV rapidly spread in the late 1960s to the Caribbean and then the United States, Europe, and other areas of the world, leading to the global AIDS pandemic. Both HIV-1 and HIV-2 descended genetically from Simian immunodeficiency virus via cross-species transmission.

Is non reactive and negative the same thing?

Nonreactive vs. A nonreactive result means that the fluid sample did not contain HIV antigens or antibodies that the test aims to react to at the time of testing. It can mean a person has tested negative for HIV. However, if an individual has a nonreactive result, it does not necessarily mean they do not have HIV.

What is distribution in epidemiology?

In the definition of epidemiology, “distribution” refers to descriptive epidemiology, while “determinants” refers to analytic epidemiology. So “distribution” covers time (when), place (where), and person (who), whereas “determinants” covers causes, risk factors, modes of transmission (why and how).

How did chimpanzees get SIV?

While monkeys have been infected with SIVs for a long time, chimps apparently acquired the virus more recently. The study shows that the SIVcpz strain arose in chimps through repeated transmission and recombination of SIVs from the red-capped mangabeys and greater spot-nosed monkeys.

Can I try for a baby while on Arvs?

Having both partners on treatment—one on PrEP and the other on antiretroviral therapy—greatly reduces the risk of HIV transmission but also protects the baby as well. If PrEP cannot be used for any reason, the couple can still conceive if the partner with HIV is virally suppressed.

How do you know if your viral load is undetectable?

A person’s viral load is considered “durably undetectable” when all viral load test results are undetectable for at least six months after their first undetectable test result. This means that most people will need to be on treatment for 7 to 12 months to have a durably undetectable viral load.

What is the difference between positive and reactive?

A reactive result can mean you had infection with the virus in the past or it can mean you are currently infected. If you did not test positive for coronavirus already, another test may be needed to see if you are currently infected.

What is HIV-1 and HIV-2?

Introduction The human immunodeficiency virus (HIV) is an enveloped retrovirus that can be categorized into two distinct subtypes – human immunodeficiency virus type 1 (HIV-1) and human immunodeficiency virus type 2 (HIV-2).

How common is HIV-1/HIV-2 in the US?

However, >99.9% of all HIV infections identified in the United States were categorized as HIV-1, and the number of HIV-2 diagnoses (mono-infection or dual-infection) remained extremely low (<0.03% of all HIV infections). In addition, the overall number of false positive HIV-2 test results produced by the HIV-1/HIV-2 differentiation increased.

Which HIV-1/HIV-2 differentiation tests are available in the US?

Two HIV-1/HIV-2 differentiation tests were available to U.S. laboratories during the analysis period: Multispot HIV-1/HIV-2 Rapid Test (Bio-Rad Laboratories), which was approved by FDA in 2004 and discontinued in 2016, and Geenius HIV-1/HIV-2 Supplemental Assay (Bio-Rad Laboratories), which was approved by FDA in 2014.

What is HIV-1 group M?

HIV-1 group M was the first lineage discovered and represents the pandemic form of the virus. Group M consists of nine viral subtypes (A–K), has a widespread distribution, and accounts for approximately 95% of all HIV-1 infections.